Abstract: Aspects described herein relate to compositions, including edible compositions, infused with nicotine compounds and methods of use for the treatment of a nicotine-related disorders. More particularly, aspects described herein relate to compositions, including edible compositions, infused with nicotine compounds that provide enhanced bioavailability of the nicotine compounds in a subject, and that mask unpleasant tastes of the nicotine compounds.

Abstract: Aspects described herein relate to improved methods for infusing compositions with lipophilic active agents, particularly methods for reducing food effect in lipophilic active agent infused compositions, such as food and beverage compositions.

Abstract: Aspects described herein relate to improved compositions and methods for transdermal and/or dermal delivery of lipophilic active agents, particularly without the need for added penetration enhancers.

Abstract: Aspects described herein relate to improved compositions and methods for infusing food and beverage compositions with PDE5 inhibitors, alone or in combination with other lipophilic active agents such as cannabinoids, nicotine, non-steroidal anti-inflammatory drugs (NSAIDs), and vitamins.

Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents involving drying methods using dielectric energy, particularly microwave energy. In some aspects, the methods further comprise dehydration using dielectric energy under vacuum and stirring at a temperature of less than 70° C.

Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.

Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.

Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.

Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.